S82387 |
GSK 4112 |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: GSK4112 (SR6452) is a Rev-erbα agonist with an EC50 value of 0.4 μM. GSK4112 can be used as a chemical tool to probe the function of Rev-erbα in transcriptional repression, regulation of circadian biology, and metabolic pathways
- 靶点: Rev-ErbBα;Autophagy
- 体外研究:
GSK4112 (0-100 μM; 1 h) interacts with Rev-erbα with an EC50 value of 0.4 μM. GSK4112 (10 μM; 6 h) represses expression of bmal1 and the target genes associated with the pathway of gluconeogenesis, recruits HDAC3 and modulates the effect of Rev-erbα on oscillation of hepatic gene expression. GSK4112 (10 μM; 16 h) reduces glucose output in murine hepatocytes. RT-PCR Cell Line: HepG2 cell line Concentration: 10 μM Incubation Time: 6 hours Result: Repressed mRNA levels of bmal1, G6 Pase, PEPCK and PGC1α.
- 体内研究:
GSK4112 (25 mg/kg; i.p. 0.5 h before Jo2 exposure) attenuates Fas-induced hepatic damage. Animal Model: Male C57BL/6 mice with Fas-induced acute hepatic damage Dosage: 25 mg/kg Administration: Intraperitoneal injection; 25 mg/kg; 0.5 h before Jo2 exposure Result: Obviously ameliorated the degree of liver damage, suppressed Jo2-induced ALT and AST increasing, improved the survival rate of mice and suppressed Fas-induced hepatocyte apoptosis.
- 参考文献:
1. Grant D, et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem Biol. 2010 Oct 15;5(10):925-932. 2. Shao R, et al. REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice. Int J Med Sci. 2021 Oct 25;18(16):3831-3838.
- 溶解性: soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.52 ml 12.598 ml 25.196 ml 5 mM 0.504 ml 2.52 ml 5.039 ml 10 mM 0.252 ml 1.26 ml 2.52 ml 50 mM 0.05 ml 0.252 ml 0.504 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)